A detailed history of Lmr Partners LLP transactions in United Therapeutics Corp stock. As of the latest transaction made, Lmr Partners LLP holds 34,600 shares of UTHR stock, worth $12.7 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
34,600
Previous 30,000 15.33%
Holding current value
$12.7 Million
Previous $9.56 Million 29.74%
% of portfolio
0.11%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$205.95 - $280.43 $1.61 Million - $2.2 Million
7,841 Added 485.81%
9,455 $2.63 Million
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $222,410 - $267,121
-1,094 Reduced 40.4%
1,614 $338,000
Q2 2022

Aug 15, 2022

BUY
$174.81 - $241.14 $473,385 - $653,007
2,708 New
2,708 $638,000
Q3 2019

Nov 14, 2019

SELL
$74.85 - $85.99 $1.95 Million - $2.24 Million
-26,064 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$76.06 - $120.81 $1.98 Million - $3.15 Million
26,064 New
26,064 $2.04 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.7B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.